A digital skin cancer prevention intervention for adolescents and their parents
Aim 1. Refine and finalize procedures and a library of sun safety and general health MMS (teen) and Facebook (parent) messages, employing user-centered design with teens and parents to ensure acceptability and engagement.
Aim 2. Conduct a single arm pilot test of SST Teen + SST Parent with 52 dyads to determine:
a) feasibility of enrolling socio-demographically diverse parent-teen dyads
b) engagement with/acceptability of the MMS intervention via message views and acceptability ratings
c) outcome data collection feasibility (i.e., daily diary, UVR exposure measured by UVR dosimeter)
d) retention rates for teens and parents at 3 and 6 months for planning study design.
- Rutgers University
Inclusion Criteria: Parents and teens are participating as dyads, meaning both the parent and the teen need to be deemed eligible based on the criteria below to be able to participate. Teens - Must be ages 13-17 years - Live with study parent equal to or greater than half time in US - Have experienced sunburn or indoor tanned in the last year or have a suboptimal sun protection score - Have no personal history of melanoma or severe medical condition that prevents participation - Have access to smartphone - Speak and read English Parents/Guardians - Must be age 18 or older - Live with a teen equal to or greater than half time in US - Have a teen who had experienced sunburn or indoor tanned in the last year or have a suboptimal sun protection score - Have no personal history of melanoma or severe medical condition that prevents participation - Have internet at home, a Facebook account, and be willing to use Facebook daily - Have access to smartphone - Speak and read English
Please note that we have obtained the inclusion and exclusion criteria information from the National Institutes of Health’s clinical trials web site ClinicalTrials.gov. The listed criteria may not necessarily reflect recent amendments to the protocol and the current criteria.
For further information about clinical trials, please contact us at 732-235-7356.